leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 00:49:52 - browse：55

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： The Bio Revolution is changing business and society

hotspot

WSS

Medical students need to learn the potent medicine of empathy

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Intermittent fasting comes with a heart risk? Not so fast

Physicians and social media: If you see something, say something?

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Louisiana bill approved classifying abortion pills as controlled substances

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

App could help diagnose ear infections more accurately — and at home

State Dept. review finds Biden bears some blame for Afghanistan failures

U.K. researchers warn about biases in medical devices, algorithms

Hepatitis C has a cure — but many Americans still lack access to it

Stop the failed accountable care organization experiment

BioMarin wins approval for gene therapy to treat hemophilia A

Why we need mandatory labeling of GMO products

Malaria cases in Florida and Texas: Here’s what you need to know

Neuroscience’s long legacy of racism

focus

Creating egg and sperm cells from stem cells raises ethical issues

Beyond aggravation: Constipation is an American epidemic

AstraZeneca to buy developer of next

U.S. death rates show how politics are affecting public health

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Orchard's therapy for neuron disease in children wins FDA approval

Wikipedia

hotspot

hotspot

focus